Tootsie Roll Industries (TR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Net product sales for Q1 2025 were $146.5M, down 3% year-over-year, with domestic sales declining 1.8% and foreign sales down 16.3% due to consumer resistance to higher prices.
Net earnings rose 14% to $18.1M, with EPS increasing to $0.25 from $0.22, aided by share repurchases.
Operating income improved to $23.1M from $11.1M, driven by higher price realization and cost reductions, despite lower sales volumes.
Market resistance to higher prices impacted sales, but margin recovery efforts and investment income supported earnings.
Financial highlights
Adjusted product cost of goods sold decreased 6.6% year-over-year, improving gross margin to 35.7% from 32.7%.
Adjusted operating income rose 5.7% to $19.4M, with adjusted operating margin up 1.2 percentage points to 13.3%.
Other income swung to a loss of $51K from a gain of $9.0M, reflecting lower investment gains on trading securities.
Cash flow from operations was $3.6M, down from $21.4M, mainly due to working capital changes.
Fewer shares outstanding in Q1 2025 due to stock repurchases supported EPS growth.
Outlook and guidance
Management expects higher cocoa and chocolate costs to pressure margins for the remainder of 2025 and into 2026 as new supply contracts at elevated prices take effect.
Ongoing plant expansion over the next seven years, with $95M–$100M in expected capital expenditures, mostly in 2025–2027, funded by internal cash flow.
Company remains cautious about passing on further input cost increases to customers.
Operating losses at the Spanish subsidiary are expected to continue beyond 2025, requiring additional cash financing.
Ongoing investments in plant operations to expand capacity and improve efficiencies.
Latest events from Tootsie Roll Industries
- Proxy covers director elections, auditor ratification, and executive pay, with strong governance.TR
Proxy filing27 Mar 2026 - 2025 earnings rose on higher sales and margin recovery, with input costs and tariffs easing ahead.TR
Q4 202512 Feb 2026 - Annual meeting to elect directors and ratify auditor, with board oversight and controlled voting.TR
Proxy Filing2 Dec 2025 - Q3 2025 saw higher sales, earnings, and margins, but input costs and tariffs remain risks.TR
Q3 20257 Nov 2025 - Q2 sales and earnings rose, but margin risks from cocoa costs and tariffs persist.TR
Q2 20258 Aug 2025 - Q3 sales fell nearly 10%, but margins and EPS improved; cocoa costs and pension risks persist.TR
Q3 202413 Jun 2025 - Earnings and EPS rose despite lower sales, but margin pressure from high cocoa costs is expected.TR
Q2 202413 Jun 2025 - Adjusted for tax effects, profit grew despite sales declines and rising input costs.TR
Q4 20245 Jun 2025